Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)	CNS demyelinating autoimmune disease, Parkinson disease, autoimmune disease, autoimmune disorder of the nervous system, basal ganglia disorder, brain disorder, central nervous system disorder, demyelinating disease, immune system disorder, movement disorder, multiple sclerosis, nervous system disorder, neurodegenerative disease, parkinsonian disorder, relapsing-remitting multiple sclerosis, synucleinopathy	Recruiting	Not applicable	2026-01-22		NCT07360977

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Azienda Sanitaria Provinciale Ragusa	1
Fondazione Edmund Mach	1
IRCCS Centro Neurolesi Bonino Pulejo	40
Vittore Buzzi Children's Hospital	3

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
IRCCS Centro Neurolesi Bonino Pulejo	Messina	Italy	2